$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
国产利妥昔单抗多少钱一支?2021利妥昔单抗价格
2025-10-19 11:44:20
Check Details
利妥昔单抗停了肾病能复发吗?
2025-10-19 11:44:20
Check Details
Loncastuximab Tesirine在复发/难治性MCL和其他B-NHL亚型患者中产生持久的反应
2025-10-19 11:44:20
Check Details
百济神州:泽布替尼获加拿大批准用于套细胞淋巴瘤
2025-10-19 11:44:20
Check Details
利妥昔单抗一个疗程价格,利妥昔单抗农合报销吗?
2025-10-19 11:44:20
Check Details
国产利妥昔单抗上市了吗?利妥昔单抗国产价格
2025-10-19 11:44:20
Check Details
Tafasitamab联合来那度胺在欧洲获批用于复发/难治性DLBCL
2025-10-19 11:44:20
Check Details
美国终于授权!FDA加速批准泽布替尼治疗复发/难治性边缘区淋巴瘤
2025-10-19 11:44:20
Check Details
利妥昔单抗国内上市了吗?2021年的医保价格是多少?
2025-10-19 11:44:20
Check Details
BRUKINSA®在澳大利亚获批治疗套细胞淋巴瘤
2025-10-19 11:44:20
Check Details
苯达莫司汀是进口药还是国产药?北京哪里有售?
2025-10-19 11:44:20
Check Details
苯达莫司汀治疗淋巴瘤的疗效如何?
2025-10-19 11:44:20
Check Details
1
2
...
7338
7339
7340
7341
7342
7343
7344
...
10233
10234
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Baxdrostat (Baxfendy) for Hypertension: Aldosterone Synthase Inhibition, Dosing, and Discontinuation Rules
2
Pixclara (Floretyrosine F-18/18F-FET) Glioma PET: Distinguishing Recurrence from Treatment-Related Change
3
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
4
Bexlutry (Lu-177 Dotatate) for SSTR-Positive GEP-NETs: PRRT Dosing and Safety Monitoring
5
Etrasimod for Ulcerative Colitis: 2mg Once Daily, Onset Timeline, and Safety Monitoring
6
Hibsago (Bepirovirsen) Japan Approval: CHB Functional Cure and B-Well Data Essentials
7
FDA Approves Isembyld (apitegromab-mstn), the World’s First Skeletal Muscle-Targeted Therapy for SMA
8
Post-Enzalutamide mCRPC: HRR/PARP, PSMA Radioligand, and Chemotherapy Sequencing
9
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
10
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
11
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
12
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend